Decreased methylation observed post‐AzaC treatment was also associated with restored WNT5A expression in 22Rv1 cells, further indicating that DNA methylation may have a functional role in regulating WNT5A gene expression during PrCa progression to metastatic disease. The gene discussed is WNT5A; the disease is metastatic neoplasm.